Xiaoting Luo

897 total citations · 1 hit paper
26 papers, 477 citations indexed

About

Xiaoting Luo is a scholar working on Molecular Biology, Oncology and Physiology. According to data from OpenAlex, Xiaoting Luo has authored 26 papers receiving a total of 477 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 6 papers in Oncology and 6 papers in Physiology. Recurrent topics in Xiaoting Luo's work include Alzheimer's disease research and treatments (4 papers), Cholinesterase and Neurodegenerative Diseases (3 papers) and Tryptophan and brain disorders (3 papers). Xiaoting Luo is often cited by papers focused on Alzheimer's disease research and treatments (4 papers), Cholinesterase and Neurodegenerative Diseases (3 papers) and Tryptophan and brain disorders (3 papers). Xiaoting Luo collaborates with scholars based in China. Xiaoting Luo's co-authors include Xing‐Mei Zhang, Yaping Wang, Fang Wang, Yan Lin, Yanyan Zeng, Linhan Wang, Hongrui Zhan, Wen Wu, Zhenguang Huang and Chunming Wang and has published in prestigious journals such as SHILAP Revista de lepidopterología, Frontiers in Immunology and European Journal of Medicinal Chemistry.

In The Last Decade

Xiaoting Luo

24 papers receiving 473 citations

Hit Papers

Hepatocellular carcinoma: signaling pathways, targeted th... 2024 2026 2025 2024 10 20 30 40 50
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Hepatocellular carcinoma: signaling pathways, targeted therapy, and immunotherapy
    2024 55 citations Xiaoting Luo, Xingmei Zhang et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaoting Luo China 12 193 81 72 63 62 26 477
Shanshan Zhang China 15 213 1.1× 47 0.6× 102 1.4× 82 1.3× 56 0.9× 40 602
Huafeng Pan China 14 313 1.6× 87 1.1× 89 1.2× 41 0.7× 62 1.0× 47 657
Shaoju Jin China 17 318 1.6× 69 0.9× 67 0.9× 45 0.7× 46 0.7× 40 647
Dan‐Dan Wen China 5 211 1.1× 102 1.3× 54 0.8× 27 0.4× 55 0.9× 8 441
Minghao Yuan China 13 225 1.2× 99 1.2× 53 0.7× 36 0.6× 58 0.9× 37 646
Ki Young Kim South Korea 17 275 1.4× 68 0.8× 42 0.6× 37 0.6× 71 1.1× 35 648
Rania M. Salama Egypt 13 198 1.0× 66 0.8× 62 0.9× 35 0.6× 57 0.9× 25 492
Xiaopeng Shi China 10 197 1.0× 38 0.5× 48 0.7× 33 0.5× 44 0.7× 47 479

Countries citing papers authored by Xiaoting Luo

Since Specialization
Citations

This map shows the geographic impact of Xiaoting Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoting Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoting Luo more than expected).

Fields of papers citing papers by Xiaoting Luo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoting Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoting Luo. The network helps show where Xiaoting Luo may publish in the future.

Co-authorship network of co-authors of Xiaoting Luo

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoting Luo. A scholar is included among the top collaborators of Xiaoting Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoting Luo. Xiaoting Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Luo, Xiaoting, et al.. (2025). C/EBPβ in Alzheimer’s disease: An integrative regulator of pathological mechanisms. Brain Research Bulletin. 221. 111198–111198. 1 indexed citations
2.
Luo, Kai, et al.. (2025). Prognostic significance of T cells and NK cells in osteosarcoma: a dual-center retrospective study. World Journal of Surgical Oncology. 23(1). 130–130.
3.
Zhang, Ting, et al.. (2024). Research Progress on the Correlation Between Hypertension and Gut Microbiota. Journal of Multidisciplinary Healthcare. Volume 17. 2371–2387. 9 indexed citations
4.
Liu, Yun, Tianyu Xie, Shangyu Liu, et al.. (2024). Single-cell and spatial transcriptomics reveal metastasis mechanism and microenvironment remodeling of lymph node in osteosarcoma. BMC Medicine. 22(1). 200–200. 20 indexed citations
5.
Luo, Xiaoting, et al.. (2023). Hormetic effects of EGC and EGCG on CES1 activity and its rescue from oxidative stress in rat liver S9. Chemico-Biological Interactions. 382. 110612–110612. 3 indexed citations
6.
Zhang, Ting, et al.. (2023). Inflammation mediated the effect of dietary fiber on depressive symptoms. Frontiers in Psychiatry. 13. 989492–989492. 6 indexed citations
7.
Luo, Xiaoting, et al.. (2023). Association Between Hemoglobin Glycation Index and Metabolic Syndrome in Middle-Aged and Older People. Diabetes Metabolic Syndrome and Obesity. Volume 16. 1471–1479. 4 indexed citations
8.
Liu, Yun, Shijie Liao, Wenyu Feng, et al.. (2023). Single-cell RNA sequencing reveals the immune microenvironment landscape of osteosarcoma before and after chemotherapy. Heliyon. 10(1). e23601–e23601. 4 indexed citations
9.
Tang, Haijun, Shangyu Liu, Xiaoting Luo, et al.. (2023). A novel molecular signature for predicting prognosis and immunotherapy response in osteosarcoma based on tumor-infiltrating cell marker genes. Frontiers in Immunology. 14. 1150588–1150588. 8 indexed citations
10.
Luo, Xiaoting, Kai Luo, Shangyu Liu, et al.. (2023). Interaction gene set between osteoclasts and regulatory CD4+ T cells can accurately predict the prognosis of patients with osteosarcoma. Cancer Science. 114(7). 3014–3026. 15 indexed citations
11.
Li, Xin, Xiaoting Luo, Yajun Chen, et al.. (2022). The Aptamer Ob2, a novel AChE inhibitor, restores cognitive deficits and alleviates amyloidogenesis in 5×FAD transgenic mice. Molecular Therapy — Nucleic Acids. 28. 114–123. 15 indexed citations
12.
Chen, Yuanyuan, et al.. (2021). miR-3113-5p, miR-223-3p, miR-133a-3p, and miR-499a-5p are sensitive biomarkers to diagnose sudden cardiac death. Diagnostic Pathology. 16(1). 67–67. 23 indexed citations
13.
Wang, Yaping, Yan Lin, Linhan Wang, et al.. (2020). TREM2 ameliorates neuroinflammatory response and cognitive impairment via PI3K/AKT/FoxO3a signaling pathway in Alzheimer’s disease mice. Aging. 12(20). 20862–20879. 131 indexed citations
14.
Liu, Yun, Wenyu Feng, Xiaoting Luo, et al.. (2019). Analysis of the clinical efficacy of tumor resection methods used in 20 patients with clavicular tumor. World Journal of Surgical Oncology. 17(1). 106–106. 6 indexed citations
15.
Ou, Chunyan, Ting Geng, Xia Gao, et al.. (2019). Systematically investigating the pharmacological mechanism of Dazhu Hongjingtian in the prevention and treatment of acute mountain sickness by integrating UPLC/Q-TOF-MS/MS analysis and network pharmacology. Journal of Pharmaceutical and Biomedical Analysis. 179. 113028–113028. 26 indexed citations
16.
Luo, Jingwen, et al.. (2018). Low molecular weight chitosan-based conjugates for efficient Rhein oral delivery: synthesis, characterization, and pharmacokinetics. Drug Development and Industrial Pharmacy. 45(1). 96–104. 21 indexed citations
17.
Luo, Xiaoting, et al.. (2017). Synthesis and evaluation of hydroxychalcones as multifunctional non-purine xanthine oxidase inhibitors for the treatment of hyperuricemia. Bioorganic & Medicinal Chemistry Letters. 27(15). 3602–3606. 35 indexed citations
18.
19.
Wei, Yinghui, et al.. (2017). Biodegradable nanoparticles for improved kidney bioavailability of rhein: preparation, characterization, plasma, and kidney pharmacokinetics. Drug Development and Industrial Pharmacy. 43(11). 1885–1891. 19 indexed citations
20.
Luo, Xiaoting, Chunming Wang, Yun Liu, & Zhenguang Huang. (2015). New multifunctional melatonin-derived benzylpyridinium bromides with potent cholinergic, antioxidant, and neuroprotective properties as innovative drugs for Alzheimer's disease. European Journal of Medicinal Chemistry. 103. 302–311. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shanshan Zhang Breakdown of academic impact, for papers by Huafeng Pan Breakdown of academic impact, for papers by Shaoju Jin Breakdown of academic impact, for papers by Dan‐Dan Wen Breakdown of academic impact, for papers by Minghao Yuan Breakdown of academic impact, for papers by Ki Young Kim Breakdown of academic impact, for papers by Rania M. Salama Breakdown of academic impact, for papers by Xiaopeng Shi
Rankless by CCL
2026